Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Vaultbit's Outlook for 2024: Comprehensive Entry into the Cryptocurrency Market and Preparation for Listing
-
Medigus Reaps Success with First Installation of a Wireless Charging System for Automatic Car Parks
-
Discovery Files NI 43-101 Technical Report for the Cordero Project Feasibility Study
-
Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
-
Glucose Health, Inc. Announces Expansion of Fiber Up® Brand – More Drink Mix Flavors and New Fiber Up® Gumdrops
-
Bombardier Announces April 3, 2024 as the Start of its New Normal Course Issuer Bid
-
BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K
-
Foundation for Sarcoidosis Research Launches Say Sarcoidosis Campaign to Shed Light on the 1.2 Million People Impacted by Sarcoidosis for April’s Awareness Month
-
Ebix Reports Conclusion of SEC Investigation and Dismissal of All Pending Securities Claims Against Ebix and its Officers in United States District Court for the Southern District of New York (SDNY)
-
GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update
-
Vital Energy Announces Offering of $100.0 Million of Senior Notes
-
Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer’s Disease on April 12, 2024
-
Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023
-
A. Duie Pyle Achieves Historic 100-Year Milestone
-
Watsco Boosts Annual Dividend 10% to $10.80 Per Share
-
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
-
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers
-
Fuse to Showcase Solutions for Networking the Battlespace at Sea-Air-Space 2024
-
Rakovina Therapeutics To Host Informational Webinar on April 3, 2024
-
Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
-
Gilat Awarded Over $13M in Additional Orders from Satellite Operators for its World Leading SkyEdge IV and SkyEdge II-c Platforms
-
20 EH/s expansion fully funded
-
DIGA Labs Announces Strategic Partnership with Ambrus Studio, Unveiling New Horizons for Web3 Gaming Communities
-
Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset
-
Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023
-
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
-
Microbix Announces Annual and Special Meeting Voting Results
-
Sachem Capital Reports Full Year 2023 Results
-
Edible Garden Reports 21.6% Year-over-Year Revenue Growth for 2023
-
Bitfarms Announces March 2024 Production and Operations Update
-
Digihost Announces 60% Month-Over-Month Increase in Cash and Crypto Position and Provides March 2024 Production Update
-
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
-
Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results
-
Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
-
Enthusiast Gaming Advances Strategic Objectives with C$4.1 Million Sale of Select Non-Core Assets
-
Telesat and Government of Canada Agree to Terms on C$2.14 Billion Loan in Support of Telesat Lightspeed
-
Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder
-
Institutional Investors Express Support For Trian’s Candidates at Disney
-
Autolus Therapeutics Announces Changes to its Board of Directors
-
The Scotts Miracle-Gro Foundation and Doodles and Digits Partner to Bring "How It's Math" to Public Television
-
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Oatly to Report First Quarter 2024 Financial Results on April 30, 2024
-
Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
-
The Scotts Miracle-Gro Foundation and Doodles and Digits Partner to Bring "How It's Math" to Public Television
-
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
-
Sachem Capital Corp. Announces Dividend of $0.11 Per Share
-
Old National Announces Completion of Merger with CapStar
-
Enservco Corporation Reports 2023 Fourth Quarter and Full Year Financial Results
-
Brown & Brown, Inc. announces 2024 first-quarter earnings release and conference call dates
